Q3 results: Nykaa, HAL, Vodafone Idea, RVNL among companies to declare earnings next week; check full list here | Stock Market News

Q3 results: Nykaa, HAL, Vodafone Idea, RVNL among companies to declare earnings next week; check full list here | Stock Market News

Source: Live Mint The Q3 FY25 earnings season, which kicked off in January, has nearly come to an end. However, around 108 companies are set to declare their financial results for the December quarter next week. Eicher Motors, Nykaa, Hindalco, Patanjali Foods, Varun Beverages, IRCTC, Lupin, Vodafone Idea, Ashok Leyland, Hindustan Aeronautics (HAL), Honasa Consumer,…

Read More
Q3 Earnings Review: Consumption slowdown, commodity weakness hurt India Inc’s profits. MOSL advises portfolio rejig | Stock Market News

Q3 Earnings Review: Consumption slowdown, commodity weakness hurt India Inc’s profits. MOSL advises portfolio rejig | Stock Market News

Source: Live Mint In a recent note, brokerage house Motilal Oswal Financial Services (MOSL) stated that a slowdown in consumption and commodity weakness have weighed on corporate earnings, even as sectors such as BFSI, Healthcare, Capital Goods, and Technology delivered strong performances. However, the government’s shift from capital expenditure to consumption in its latest budget…

Read More
PC Jeweller Q3 Results: Jewellery maker posts  ₹148 crore profit vs loss YoY; revenue jumps multifold | Stock Market News

PC Jeweller Q3 Results: Jewellery maker posts ₹148 crore profit vs loss YoY; revenue jumps multifold | Stock Market News

Source: Live Mint PC Jeweller Q3 Results: PC Jeweller Limited announced its October to December quarter results on Tuesday, February 4. The jewellery maker posted a ₹148 crore net profit for the third quarter of the financial year 2024-25.  The firm recorded a net loss of ₹197.98 crore in the same quarter the previous year,…

Read More
Alembic Pharma Q3 Results: Consolidated net profit declines 23% to  ₹138 crore, stock down 5% | Stock Market News

Alembic Pharma Q3 Results: Consolidated net profit declines 23% to ₹138 crore, stock down 5% | Stock Market News

Source: Live Mint Alembic Pharmaceuticals posted its results for the quarter ended December 2024 (Q3FY25). Its consolidated net profit tumbled 23.29 percent to ₹138.42 crore in Q3 FY25, compared with ₹180.45 crore posted in Q3 FY24. However, revenue from operations was at ₹1,692.74 crore in the third quarter of FY25, up 3.81 percent year on…

Read More